B-cell ALL

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:healthcare_organization
gptkbp:affects gptkb:B_lymphocytes
gptkbp:age gptkb:Person
young adults
gptkbp:associated_with gptkb:Philadelphia_chromosome
central nervous system involvement
hyperleukocytosis
gptkbp:clinical_trial gptkb:vaccine
targeted therapies
new therapies
gptkbp:complications gptkb:healthcare_organization
organ damage
bleeding disorders
gptkbp:end_of_life lower in adults
higher in children
gptkbp:events psychosocial support
regular blood tests
monitoring for relapse
https://www.w3.org/2000/01/rdf-schema#label B-cell ALL
gptkbp:is_involved_in gptkb:Leukemia_&_Lymphoma_Society
gptkb:Cancer_Support_Community
local cancer support groups
gptkbp:is_often_used_in males
Caucasian populations
African American populations
Hispanic populations
gptkbp:research_focus genetic mutations
long-term effects of treatment
treatment resistance
gptkbp:risk_factor genetic disorders
exposure to radiation
previous chemotherapy
gptkbp:social_responsibility blood tests
varies by age
bone marrow biopsy
C D19
C D22
Td T
varies by genetic factors
gptkbp:symptoms fatigue
weight loss
fever
pale skin
easy bruising
gptkbp:treatment gptkb:drug
radiation therapy
chemotherapy
remission
stem cell transplant
maintenance therapy
consolidation therapy
induction therapy
gptkbp:type_of gptkb:Burkitt_leukemia
gptkb:Ph-positive_ALL
gptkb:Precursor_B-cell_ALL